Aetion

New eBook: The role of real-world evidence in FDA approvals. Download now.

Publications using Aetion Evidence Platform®

Aetion Evidence Platform is used by leading academics worldwide in their peer-reviewed research. The platform is also used in database analytics and comparative effectiveness courses taken by epidemiologists, outcomes researchers, health economists and biostatisticians.

Selected Publications

Below is a selection of peer-reviewed publications and abstracts using Aetion Evidence Platform analytics, or by Aetion authors. For our full publications list, please contact pubs@aetion.com.

See here for how to cite Aetion Evidence Platform in your publications.

Emulating randomized clinical trials with nonrandomized real-world evidence studies: First results from the RCT DUPLICATE initiative.

Circulation
Franklin JM, Patorno E, Desai RJ, Glynn RJ, Martin D, Quinto K, Pawar A, Bessette LG, Lee H, Garry EM, Gautam N, Schneeweiss S 2020 December. doi: https://doi.org/10.1161/CIRCULATIONAHA.120.051718.

Utilization and spending on potentially inappropriate medications by U.S. older adults with multiple chronic conditions using multiple medications.

Archives of Gerontology and Geriatrics
Jungo KT, Streit S, Julie SS, Lauffenburger JC 2020 December. doi: https://doi.org/10.1016/j.archger.2020.104326.

Chronic kidney disease progression among patients with type 2 diabetes identified in US administrative claims: A population cohort study.

Clinical Kidney Journal
Kovesdy CP, Isaman D, Petruski-Ivleva N, Fried L, Blankenburg M, Gay A, Velentgas P, Folkerts K 2020 December. doi: https://doi.org/10.1093/ckj/sfaa200.

Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database.

Journal of Managed Care & Specialty Pharmacy
Folkerts K, Petruski-Ivleva N, Kelly A, Fried L, Blankenburg M, Gay A, Kovesdy CP 2020 December. doi: 10.18553/jmcp.2020.26.12.1506.

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.

Science
Gordon D, et al. 2020 December. doi: 10.1126/science.abe9403.

Renin-Angiotensin-Aldosterone-System inhibitor use in patients with COVID-19 infection and prevention of serious events: A cohort study in commercially insured patients in the U.S.

medRxiv
Schneeweiss MC, Leonard S, Weckstein A, Schneeweiss S, Rassen J 2020 July 24. doi: https://doi.org/10.1101/2020.07.22.20159855.

Real‐world reproducibility study characterizing patients newly diagnosed with multiple myeloma using Clinical Practice Research Datalink, a UK‐based electronic health records database.

Pharmacoepidemiology & Drug Safety
Seesaghur A, Petruski‐Ivleva N, Banks V, Wang JR, Mattox P, Hoeben E, Maskell J, Neasham D, Reynolds SL, Kafatos G 2020 Nov 10. doi/10.1002/pds.5171.

Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in SSc and SSc-ILD: a US cohort study.

Rheumatology
Li Q, Wallace L, Patnaik P, Alves M, Gahlemann M, Kohlbrenner V, Raabe C, Wang JR, Garry EM 2020 Nov 6:keaa547. doi: 10.1093/rheumatology/keaa547. Epub ahead of print. PMID: 33155024.

Determining the suitability of registries for embedding clinical trials in the United States: A project of the Clinical Trials Transformation Initiative.

Therapeutic Innovation & Regulatory Science
Mikita JS, Mitchel J, Gatto NM, Laschinger J, Tcheng JE, Zeitler EP, Swern AS, Flick ED, Dowd C, Lystig T, Calvert SB 2020 June. doi: 10.1007/s43441-020-00185-5.

Cardiovascular outcomes in older adults initiating empagliflozin vs. DPP-4 inhibitors and GLP-1 receptor agonists: A subgroup analysis from the EMPRISE study.

Diabetes
Patorno E, Pawar A, Bessette LG, Najafzadeh M, Wexler DJ, Franklin J, Deruaz-Luyet A, Brodovicz K, Koeneman L, Schneeweiss S 2020 June. doi: 10.2337/db20-133-LB.

To cite Aetion Evidence Platform® in publications, use:

Aetion Evidence Platform® (2020). Software for real-world data analysis. Aetion, Inc. http://aetion.com

or

Aetion Evidence Platform® (2020). Software for real-world data analysis, which is validated for a range of studies.* Aetion, Inc. http://www.aetion.com
‍
* Wang SV, et al. Transparency and Reproducibility of Observational Cohort Studies Using Large Healthcare Databases. Clin Pharmacol Ther. 2016 Mar;99(3):325-332. doi: 10.1002/cpt.329

The Evidence Digest

Subscribe to our newsletter for insights and updates on research and applications for real-world evidence in life sciences and value-based health care.

arrowcalendarchevronclosecollapsecountdownfacebookflickrinstagramlinelinkedinlocationpinsearchsocialtwitteryoutube